Newswise — Progress in a large-scale effort by the PhRMA Foundation to improve health care value-assessment will be highlighted during the national conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) next week in New Orleans. To date, the Foundation has invested $2.8 million to support a variety of value-assessment research efforts, including the establishment of four value-assessment Centers of Excellence.

A special session to be held Wednesday, May 22 from 9:45 to 10:45 a.m. will feature reports from leaders of the Foundation’s four Centers of Excellence, which have been established by the University of Maryland, Baltimore, University of Colorado, Tufts Medical Center and Altarum/V-BID Health. The centers are using new and diverse approaches to capture and measure value. The session will be held in Room 386-387 (3rd Floor) of the New Orleans Ernest N. Morial Convention Center.

Upon conclusion of the session, the Foundation will present its 2019 awards in Health Outcomes and Value Assessment to recognize the award recipients and promote these two areas of support of young scientists and research efforts.

Speakers during the session will include Susan dosReis, PhD, of the University of Maryland School of Pharmacy in Baltimore, Maryland; George Miller, PhD, of Altarum, based in Ann Arbor, Michigan; Jonathan D. Campbell, PhD, of the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado; and Peter J. Neumann, ScD, of Tufts Medical Center in Boston, Massachusetts. Moderating the session will be Sachin Kamal-Bahl, PhD, of SKB Consulting Inc., based in Philadelphia, Pennsylvania.

“With health care costs continuing to rise, there is a greater need than ever for improvements in the health care system that promote high-quality care while avoiding low-value or inefficient care,” said PhRMA Foundation President Eileen Cannon. “The Foundation is strongly positioned to help move this important national effort forward, with our long history of finding and supporting innovative scientific researchers with grants and fellowships. We are confident that the important work of our Centers of Excellence will ultimately improve the lives of patients and families – and we are excited information about their activities will be shared during the upcoming ISPOR meeting.”

In addition to the PhRMA Foundation session, representatives of several of the Foundation’s Centers of Excellence will also be involved in other value assessment-related activities during the conference. The University of Maryland’s Patient-Driven Values in Healthcare Evaluation (PAVE), the University of Colorado’s pValue Center, and Tufts’ Center for Enhanced Value Assessment (CEVA) all will participate in sessions ranging from value assessment workshops to panel discussions and poster sessions. To learn more about these activities and other events at the ISPOR conference, visit

The Foundation’s Value Assessment Initiative is designed to improve patient outcomes while reducing inefficiencies in health care by developing better methods for assessing the value of medicines and health care services. Through its funding, the Foundation is encouraging more evidence-based research on how the true value of medicines can be accurately defined and quantified. It was launched in 2017 and includes funding for the efforts of individual researchers in addition to the establishment of the four Value Assessment Centers of Excellence.

For more information about each of the Centers of Excellence, please visit:

For more information about the PhRMA Foundation’s Value Assessment Initiative, visit

About the PhRMA Foundation

For more than 50 years, the PhRMA Foundation has been helping to build a larger pool of highly-trained, top-quality scientists to meet the growing needs of scientific and academic institutions, government, and the research-intensive pharmaceutical industry. To advance this mission, the PhRMA Foundation has awarded more than $90 million in competitive research fellowships and grants since its founding. The Foundation’s emphasis on evidence-based research that determines the true value of medicines is supported by its Value Assessment Initiative. To date, the Foundation has awarded more than $2.8 million to support a variety of research projects to help advance this goal, including the establishment of four national Centers of Excellence in Value Assessment.


To learn more, please visit

Register for reporter access to contact details